Sinopharm Group Co Ltd (SHTDF)
2.49
0.00 (0.00%)
USD |
OTCM |
Jan 21, 16:00
Key Stats
Price and Performance | |
---|---|
Market Cap | 7.770B |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | -2.15% |
Valuation | |
PE Ratio | -- |
PE Ratio (Forward) | Upgrade |
PS Ratio | -- |
Price to Book Value | 0.7476 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | 0.1224 |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | -- |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 62.86% |
Profile
Edit
Sinopharm Group was founded in 2003 and listed on the Hong Kong Stock Exchange in September 2009. Its main business is drug distribution in mainland China, which contributes about 75% of total revenue. It is the largest drug distributor, with approximately 20% market share. Other notable segments are medical device distribution, which contributes about 20% of revenue, and retail pharmacies, which contributes about 5%. These are fast-growing industries, where government policy is designed to encourage consolidation and promote large players with scale and efficiency advantages. |
URL | http://www.sinopharmgroup.com.cn |
Investor Relations URL | http://ir.sinopharmgroup.com.cn/ |
HQ State/Province | N/A |
Sector | Health Care |
Industry | Health Care Providers & Services |
Next Earnings Release | Aug. 26, 2025 (est.) |
Last Earnings Release | Oct. 28, 2024 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | Jun. 17, 2024 |
Ratings
Profile
Edit
Sinopharm Group was founded in 2003 and listed on the Hong Kong Stock Exchange in September 2009. Its main business is drug distribution in mainland China, which contributes about 75% of total revenue. It is the largest drug distributor, with approximately 20% market share. Other notable segments are medical device distribution, which contributes about 20% of revenue, and retail pharmacies, which contributes about 5%. These are fast-growing industries, where government policy is designed to encourage consolidation and promote large players with scale and efficiency advantages. |
URL | http://www.sinopharmgroup.com.cn |
Investor Relations URL | http://ir.sinopharmgroup.com.cn/ |
HQ State/Province | N/A |
Sector | Health Care |
Industry | Health Care Providers & Services |
Next Earnings Release | Aug. 26, 2025 (est.) |
Last Earnings Release | Oct. 28, 2024 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | Jun. 17, 2024 |